Clinical Trials Directory

Trials / Completed

CompletedNCT03225066

Efficacy and Safety of Poly-L-lactic Acid

A Prospective, Randomized, Multicenter, Self-controlled, Blinded Trial on the Efficacy and Safety of Poly-L-lactic Acid - SCULPTRA - for the Treatment of Corporal Skin Flaccidity.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Galderma Brasil Ltda. · Industry
Sex
Female
Age
35 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study aims to assess efficacy and safety of Sculptra in the treatment of skin flaccidity in selected areas - arms, anteromedial region, and gluteal regions. To assess the efficacy of Sculptra®, via adapted Global Aesthetic Improvement Scale -GAIS- score determined by blind evaluator, in the treatment of skin flaccidity on the anteromedial region of arm and gluteal region, 4 months after initiating the treatment, based on the assessment of the corporal side randomized to be the first to receive treatment . Considering as an alternative hypothesis of interest a 70% value of the subjects the treated side would have higher GAIS than the untreated side.

Detailed description

Ethical and General considerations regarding the study conduction: This study protocol will be reviewed and approved by appropriate IEC/IRB prior to the initiation of the study. Clinical monitoring: Study conduction will be closely monitored by Galderma representatives, following GCP regulations, applicable standard operating procedures, guides and local regulations. Data Management: Data may be audited by Galderma Quality Assurance Department and/or CRO prior to or after results of the first statistical analysis on the primary discretion. Quality assurance, auditing and Inspection: The study will be carried out under the sponsorship of Galderma in accordance with all local and federal regulations, as well as ICH guidelines. Audits and inspections at the research site may be conducted by Galderma representatives or local authorities. All aspects in any study step can be audited by Galderma Quality Assurance / CRO and, as a result, a certificate stating this will be provided.

Conditions

Interventions

TypeNameDescription
DEVICEPoly-L-lactic acid - SculptraParticipants using Sculptra - Poly-L-lactic acid 3 sessions in the first side and 3 sessions on the second side

Timeline

Start date
2017-08-21
Primary completion
2018-01-10
Completion
2018-01-10
First posted
2017-07-21
Last updated
2018-03-29

Locations

4 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03225066. Inclusion in this directory is not an endorsement.